Saleh, N.; Allam, T.; Korany, R.M.S.; Abdelfattah, A.M.; Omran, A.M.; Abd Eldaim, M.A.; Hassan, A.M.; El-Borai, N.B.
Protective and Therapeutic Efficacy of Hesperidin versus Cisplatin against Ehrlich Ascites Carcinoma-Induced Renal Damage in Mice. Pharmaceuticals 2022, 15, 294.
https://doi.org/10.3390/ph15030294
AMA Style
Saleh N, Allam T, Korany RMS, Abdelfattah AM, Omran AM, Abd Eldaim MA, Hassan AM, El-Borai NB.
Protective and Therapeutic Efficacy of Hesperidin versus Cisplatin against Ehrlich Ascites Carcinoma-Induced Renal Damage in Mice. Pharmaceuticals. 2022; 15(3):294.
https://doi.org/10.3390/ph15030294
Chicago/Turabian Style
Saleh, Nahed, Tamer Allam, Reda M. S. Korany, Abdelfattah M. Abdelfattah, Ahmed M. Omran, Mabrouk Attia Abd Eldaim, Aziza M. Hassan, and Nermeen Borai El-Borai.
2022. "Protective and Therapeutic Efficacy of Hesperidin versus Cisplatin against Ehrlich Ascites Carcinoma-Induced Renal Damage in Mice" Pharmaceuticals 15, no. 3: 294.
https://doi.org/10.3390/ph15030294
APA Style
Saleh, N., Allam, T., Korany, R. M. S., Abdelfattah, A. M., Omran, A. M., Abd Eldaim, M. A., Hassan, A. M., & El-Borai, N. B.
(2022). Protective and Therapeutic Efficacy of Hesperidin versus Cisplatin against Ehrlich Ascites Carcinoma-Induced Renal Damage in Mice. Pharmaceuticals, 15(3), 294.
https://doi.org/10.3390/ph15030294